Weight loss company Noom Inc. is following Weight Watchers in launching a program that includes access to a suite of telehealth services and weight-loss drugs along with Noom’s personalized psychological tools for weight loss.

Noom Med is available for people with a BMI of 30 or higher, or greater than or equal to 27 accompanied by a weight-related medical condition. The company said the introduction of GLP-1 medications like Wegovy and Ozempic for obesity care “has revolutionized the landscape…

[wpcode id="4722"]

[zmauto id = 1]